Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Iambic Raises Over $100 Million to Advance AI-Discovered Therapeutics and Platform Technologies
Life Sciences Times
-
November 10, 2025
0
Venture Capital
Revvity to Acquire ACD/Labs to Enhance Signals Software Platform
Life Sciences Times
-
November 10, 2025
0
Venture Capital
Sovato Closes $41 Million Series B to Advance the World’s First Remote Robotic Surgery and Procedure Platform
Life Sciences Times
-
November 4, 2025
0
Venture Capital
Outcome Capital Launches Dedicated Healthcare Services Practice to Strengthen Strategic Advisory and Investment Banking Capabilities
Life Sciences Times
-
November 4, 2025
0
Venture Capital
Courage Therapeutics Secures Seed Funding to Advance Melanocortin-Based Obesity and Wasting Disease Programs
Life Sciences Times
-
November 3, 2025
0
Venture Capital
UPS Completes $1.6 Billion Acquisition of Andlauer Healthcare Group to Strengthen Global Healthcare Logistics
Life Sciences Times
-
November 3, 2025
0
Venture Capital
Mind Medicine Announces Pricing of $225 Million Public Offering
Life Sciences Times
-
October 30, 2025
0
Venture Capital
Helex Raises $3.5 Million in Seed Funding to Advance Non-Viral Gene Therapies for Kidney Diseases
Life Sciences Times
-
October 30, 2025
0
Venture Capital
Curve Biosciences Raises $40 Million to Advance Whole-Body Intelligence Platform for Chronic Disease Monitoring
Life Sciences Times
-
October 29, 2025
0
Biotech
iOrganBio Launches from Stealth with $2 Million in Funding and Introduces CellForge, the First AI-Powered Cell Manufacturing Platform
Life Sciences Times
-
October 29, 2025
0
Venture Capital
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development
Life Sciences Times
-
October 29, 2025
0
Venture Capital
Hovione Completes $100 Million Expansion to Grow U.S. Manufacturing Operations in New Jersey
Life Sciences Times
-
October 27, 2025
0
1
...
7
8
9
...
115
Page 8 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026